Related Experiment Video
Updated: Jul 15, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy
Puneet Kakar1, Gregory Y H Lip
1Hemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Expert Review of Cardiovascular Therapy
|May 11, 2007
Summary
Essential hypertension involves inflammation and endothelial dysfunction, leading to a prothrombotic state. Antithrombotic therapy is recommended for secondary prevention, but its role in primary prevention and interactions with other drugs require further study.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Pharmacology
Background:
- Essential hypertension research increasingly focuses on inflammation and endothelial dysfunction.
- Inflammation and endothelial dysfunction are linked to thrombogenesis and atherogenesis.
- Hypertension creates a prothrombotic state, paradoxically leading to thrombotic rather than hemorrhagic complications.
Purpose of the Study:
- To explore the role of inflammation and endothelial dysfunction in hypertension pathophysiology.
- To investigate the 'thrombotic paradox of hypertension'.
- To define the role of antithrombotic therapy in primary and secondary prevention of hypertension complications.
Main Methods:
- Review of current research on hypertension pathophysiology, inflammation, and endothelial function.
- Analysis of clinical data regarding thrombotic events in hypertensive patients.
- Evaluation of guidelines and evidence for antithrombotic therapy in hypertension.
Main Results:
- Inflammation and endothelial dysfunction are key contributors to hypertension complications.
- The 'thrombotic paradox' highlights the tendency for thrombotic events despite high blood pressure.
- Antithrombotic therapy is established for secondary prevention but less defined for primary prevention.
Conclusions:
- Understanding inflammation and endothelial dysfunction is crucial for managing hypertension.
- Further research is needed to clarify the optimal use of antithrombotic agents in primary hypertension prevention.
- Interactions between aspirin and ACE inhibitors warrant further investigation for secondary prevention.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...